Noticias de AKTX_US

Noticias del mercado

Últimas noticias sobre AKTX_US — 139 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: AKTX_US ✕ 139 resultados
10/04/2026 AKTX_US — Yahoo Finance
Akari Therapeutics downgraded to Hold from Buy at Maxim
09/04/2026 AKTX_US — Stock Titan
Akari says WuXi XDC deal clears faster path for lead drug toward human studies
09/04/2026 AKTX_US — Quiver Quantitative
Akari Therapeutics CEO Abizer Gaslightwala Discusses Strategic Partnership with WuXi XDC and Accelerated IND Timeline for AKTX-101
07/04/2026 AKTX_US — BioWorld News
Akari Therapeutics partners with Wuxi XDC on ADC payload
06/04/2026 AKTX_US — Yahoo Finance
Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing
06/04/2026 AKTX_US — Investing.com
Akari Therapeutics partners with WuXi XDC on ADC development
06/04/2026 AKTX_US — The Legal Advocate
Is Akari (AKTX) Stock Testing Support | AKTX Q4 Earnings: Beats Estimates by $1.53 - Pre-Announcement Alert
06/04/2026 AKTX_US — Contract Pharma
Akari Therapeutics Partners with WuXi XDC to Accelerate Development of Novel PH1 Payload
06/04/2026 AKTX_US — Stock Titan
Cancer drug developer taps WuXi to push RNA-splicing therapy to clinic
06/04/2026 AKTX_US — Quiver Quantitative
Akari Therapeutics Partners with WuXi XDC to Accelerate Development of Novel PH1 ADC Payload | AKTX Stock News
06/04/2026 AKTX_US — The Legal Advocate
Is Akari (AKTX) Stock in an Uptrend | Price at $4.07, Down 8.95% - Monthly Profile
31/03/2026 AKTX_US — Minichart
Akari Therapeutics Plc 2025 Annual Report – Warrants, Private Placements, and Business Acquisition Details
19/03/2026 AKTX_US — ChartMill
Get insights into the top gainers and losers of Thursday's after-hours session.
19/03/2026 AKTX_US — minichart.com.sg
Akari Therapeutics Announces ADS Ratio Change to Maintain Nasdaq Compliance and Highlights Oncology Pipeline Progress 1
17/03/2026 AKTX_US — Stock Titan
Akari Therapeutics (NASDAQ: AKTX) plans 1-for-40 ADS ratio change to meet Nasdaq bid rules
17/03/2026 AKTX_US — Investing.com
Akari Therapeutics adjusts ADS ratio to meet Nasdaq rules
17/03/2026 AKTX_US — GuruFocus
Akari Therapeutics (AKTX) Alters ADS to Ordinary Shares Ratio
17/03/2026 AKTX_US — TipRanks
Akari Therapeutics Announces ADS Ratio Change, Reverse Split
16/03/2026 AKTX_US — Stock Titan
Director Neal James acquires Akari (AKTX) ADS warrants via placement and note swap

Página 7 de 7

keyboard_arrow_up